File:Staphylococcus aureus VISA 2.jpg - Wikimedia Commons
Health: Infectious Disease Epidemiology & Prevention Division: Vancomycin-Intermediate/Vancomycin-Resistant Staphylococcus aureus (VISA /VRSA)
Vancomycin-resistant Staphylococcus aureus - Wikipedia
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India | PLOS ONE
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. | Semantic Scholar
Investigation and Control of Vancomycin-Intermediate Staphylococcus aureus
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA. | Semantic Scholar
VISA/VRSA in Healthcare Settings | HAI | CDC
MRSA. Staphylococcus aureus methicillin resistant
VISA/VRSA Infections
Staphylococcus aureus, Resistant or Intermediate Resistant to Vancomycin ( VISA, VRSA) | Ohio Department of Health
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea | Scientific Reports
Why Sequence Staphylococcus aureus VISA Strains? - DOE Joint Genome Institute
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus - ScienceDirect
Vancomycin Intermediate/Resistant Staphylococcus aureus - Quip Labs
Frontiers | Rapid Detection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Based on Matrix-Assisted Laser Desorption Ionization Time-of-Flight: Using a Machine Learning Approach and Unbiased Validation
Vancomycin-resistant Staphylococcus aureus laboratory findings - wikidoc
Microorganisms | Free Full-Text | Vancomycin Resistance in Enterococcus and Staphylococcus aureus
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications | Clinical Microbiology Reviews
Microbiology Case Study: A 37 Year Old Man with Endocarditis – Lablogatory
Overview of some general cell wall characteristics of VSSA and VISA... | Download Scientific Diagram
Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features - ScienceDirect
Colonies formed by the vancomycin intermediateresistant S. aureus... | Download Scientific Diagram
Toxins | Free Full-Text | In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus
Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate Staphylococcus aureus (VISA)
KEGG PATHWAY: Staphylococcus aureus infection - Staphylococcus aureus subsp. aureus JH9 (MRSA/VISA)
JCI - Antimicrobial resistance: the example of Staphylococcus aureus
